Bone diseases: Dual sclerostin-DKK1 antibody outperforms monotherapy.

Nature reviews. Endocrinology

PubMedID: 27312866

Holmes D. Bone diseases: Dual sclerostin-DKK1 antibody outperforms monotherapy. Nat Rev Endocrinol. 2016;.
An abstract is not available. Please access the article through the links below.